Targeting Two-Component Signal Transduction: A Novel Drug Discovery System

Methods in Enzymology

Volumn 422, Issue , 2007, Pages 386-395

  Okada, Ario ^a   Gotoh, Yasuhiro ^a   Watanabe, Takafumi ^a   Furuta, Eiji ^a   Yamamoto, Kaneyoshi ^a   Utsumi, Ryutaro ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 BENZYL 1 LAURYL 2 METHYLIMIDAZOLIUM IODIDE; AMIKACIN; CEFAZOLIN; ERYTHROMYCIN; IMIDAZOLE DERIVATIVE; NH 127; OFLOXACIN; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN HISTIDINE KINASE; UNCLASSIFIED DRUG; VANCOMYCIN;

AUTOPHOSPHORYLATION; BACILLUS SUBTILIS; BACTERIAL STRAIN; BACTERIUM MUTANT; DIMERIZATION; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG SENSITIVITY; ENZYME PHOSPHORYLATION; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TEMPERATURE SENSITIVE MUTANT;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS);

EID: 34447108830     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)22019-6     Document Type: Chapter

References (22)

1. Barrette J.F., and Hoch J.A. Two-component signal transduction as a target for microbial anti-infective therapy. Antimicrob. Agents Chemother. 42 (1998) 1529-1536
2. Beir D., and Frank R. Molecular characterization of two-component systems of Helicobacter pylori. J. Bacteriol. 182 (2000) 2068-2076
3. Eguchi Y., Oshima T., Mori H., Aono R., Yamamoto K., Ishihama A., and Utsumi R. Transcriptional regulation of efflux genes by EvgAS, a two-component system in Escherichia coli. Microbiology 149 (2003) 2819-2828
4. Fabret C., and Hoch J.A. A two-component signal transduction system essential for growth of Bacillus subtilis: Implications for anti-infective therapy. J. Bacteriol. 180 (1998) 6375-6383
5. Fukuchi K., Kasahara Y., Asai K., Kobayashi K., Moriya S., and Ogasawara N. The essential two-component regulatory system encoded by yycF and yycG modulates expression of the ftsAZ operon in Bacillus subtilis. Microbiology 146 (2000) 1573-1583
6. Furuta E., Yamamoto K., Tatebe D., Watabe K., Kitayama T., and Utsumi R. Targeting protein homodimerization: A novel drug discovery system. FEBS Lett. 579 (2005) 2065-2070
7. Hancock L., and Perego M. Two-component signal transduction in Enterococcus faecalis. J. Bacterial. 184 (2002) 5819-5825
8. Hidaka Y., Park H., and Inouye M. Demonstration of dimer formation of the cytoplasmic domain of a transmembrane osmosensor protein, EnvZ of Escherichia coli using N-histidine tag affinity chromatography. FEBS Lett. 400 (1997) 238-243
9. Hirakawa H., Nishino K., Hirota Y., and Yamaguchi A. Comprehensive studies of drug resistance mediated by over-expression of response regulators of two-component signal transduction system in Escherichia coli. J. Bacteriol. 185 (2003) 1851-1856
10. Kato A., Ohnishi H., Yamamoto K., Furuta E., Tanabe H., and Utsumi R. Transcription of emrKY is regulated by the EvgA-EvgS two-component system in Escherichia coli K-12. Biosci. Biotechnol. Biochem. 64 (2000) 1203-1209
11. Lange R., Wagner C., de Saizieu A., Flint N., Molnos J., Stieger M., Caspers P., Kamber M., Keck W., and Amrein K.E. Domain organization and molecular characterization of 13 two-component systems identified by genome sequencing of Streptococcus pneumoniae. Gene 237 (1999) 223-234
12. Macielag M.J., and Goldschmidt R. Inhibitors of bacterial two-component signaling systems. Exp. Opin. Invest. Drugs 9 (2000) 2351-2369
13. Martin P.K., Li T., Sun D., Biek D.P., and Schmid M.B. Role in cell permeability of an essential two-component system in Staphylococcus aureus. J. Bacteriol. 181 (1999) 3666-3673
14. Matsushita M., and Janda K.D. Histidine kinases as targets for new antimicrobial agents. Bioorg. Med. Chem. 10 (2002) 855-867
15. Moir D.T., Shaw K.J., Hare R.S., and Voris G.F. Genomics and antimicrobial drug discovery. Antimicrob. Agents Chemother. 43 (1999) 439-446
16. Silhavy T.J., Berman M.L., and Enquist L.W. Preparation of SDS protein extracts. "Experiments with Gene Fusions," (1984), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 208-212
17. Throup J.P., Koretke K.K., Bryant A.P., Ingraham K.A., Chalker A.F., Ge Y., Marra A., Wallis N.G., Brown J.R., Holmes D.J., Rosenberg M., and Burnham M.K. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol. Microbiol. 35 (2000) 566-576
18. Tomomori C., Tanaka T., Dutta R., Park H., Saha S.K., Zhu Y., Ishima R., Liu D., Tong K.I., Kurokawa H., Qian H., Inouye M., and Ikura M. Solution structure of the homodimeric core domain of Escherichia coli histidine kinase EnvZ. Nat. Struct. Biol. 6 (1999) 729-734
19. Watanabe T., Hashimoto Y., Umemoto Y., Tatebe D., Furuta E., Fukamizo T., Yamamoto K., and Utsumi R. Molecular characterization of the essential response regulator protein YycF in Bacillus subtilis. J. Mol. Microbiol. Biotechnol. 6 (2003) 155-163
20. Watanabe T., Hashimoto Y., Yamamoto K., Hirao K., Ishihama A., Hino M., and Utsumi R. Isolation and characterization of inhibitors of the essential histidine kinase, YycG in Bacillus subtilis and Staphylococcus aureus. J. Antibiot. 56 (2003) 1045-1052
21. Yamamoto K., Kitayama T., Ishida N., Watanabe T., Tanabe H., Takatani M., Okamoto T., and Utusmi R. Identification and characterization of a potent antibacterial agent, NH125 against drug-resistant bacteria. Biosci. Biotechnol. Biochem. 64 (2000) 912-923
22. Yamamoto K., Kitayama T., Minagawa S., Watanabe T., Sawada S., Okamoto T., and Utsumi R. Antibacterial agents that inhibit histidine protein kinase YycG of Bacillus subtilis. Biosci. Biotechnol. Biochem. 65 (2001) 2306-2310